Towa Pharmaceutical Co (JP:4553) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Towa Pharmaceutical Co. has revised its financial forecasts upward for the fiscal year ending March 31, 2025, driven by strong overseas sales and lower-than-expected R&D expenses. The company now expects significant increases in profits and earnings per share due to favorable foreign exchange gains and operational efficiency.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.
